Código QR (código de barras bidimensional)

Estimating the Public Health and Economic Impact of Immunisation with Nirsevimab or Maternal Immunisation for the Prevention of RSV-Related Outcomes Over Infants’ First RSV Season in the UK

Abstract Introduction Respiratory syncytial virus (RSV) poses a significant health burden on infants, particularly during their first RSV season. Immunoprophylactic strategies, such as the administration of nirsevimab, a long-acting monoclonal antibody, have been developed to prevent RSV lower respi...

ver descrição completa

Na minha lista:
Principais autores: Mersha Chetty, Paul Costello, Benjamin Yarnoff, Robert Musci, Mehdi Ghemmouri
Formato: Artigo
Idioma:Inglês
Publicado em: Adis, Springer Healthcare 2025-07-01
coleção:Infectious Diseases and Therapy
Assuntos:
RSV
Nirsevimab
Maternal immunisation
Economic burden
Lower respiratory tract disease
Infants
Acesso em linha:https://doi.org/10.1007/s40121-025-01194-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados